Boston, MA · Founded 2019 · Privately Held (backing)
Developer of an artificial intelligence-based neurotechnology platform designed for accelerating the clinical development of therapeutics targeting brain health. Beacon Biosignals is based in Boston, MA and was founded in 2019. It was valued at $334 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $127 million across 2 recorded rounds; the latest was a $103 million later-stage round in Oct 2025.
PMV mark · valuation
$334.0M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$126.9M
Last round
Later Stage VC
Oct 2025
Team — not yet on record
No current team members for Beacon Biosignals are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Beacon Biosignals with a free account
·The complete investor list: 20 names
·Watch Beacon Biosignals: the Monday email on marks, rounds and moves
